Follow us on X: @ERINHA_RI

Access to our intranet here

Download our portfolio here

ISIDORe First Call Dedicated To SARS-CoV-2 and COVID-19 Is Open For Applications

Juin 17, 2022

3 June 2022
The Integrated Services for Infectious Disease Research (ISIDORe) announces the launch of its first call for proposals, open to all, to support scientists with an interest in SARS-CoV-2 and COVID-19.
The requests for free of charge transnational access to ISIDORe services for supporting and advancing research must be focused on one of the topics listed on the ISIDORe website. Applications will be evaluated, selected and implemented on a rolling basis as long as funding remains available.
The first call is divided into six main sections which are: Surveillance & Epidemic Risk Management; Understanding SARS-CoV-2 & Covid-19; Diagnostics; Therapeutics; Vaccines; and Social Sciences & Epidemiology.
The call is multidisciplinary and open to all scientists both from academia and private sector.
The users wishing to benefit from the support of ISIDORe are requested to submit proposals that will be evaluated based on their feasibility and scientific merit (independent peer review).

For any requests please contact us
Read more on application modalities on the ISIDORe website.
Follow us on Twitter and stay informed.

About ISIDORe

ISIDORe, an interdisciplinary project coordinated by European Research Infrastructure on Highly Pathogenic Agents (ERINHA), is funded by the European Commission Horizon-Europe programme through the HERA incubator call and brings together all key European life-sciences research infrastructures and networks, as well as those in the social sciences.
The Consortium brings together 154 partners under the umbrella of BBMRI, EATRIS, ECRIN, ELIXIR, EMBRC, EMERGEN, EUOPENSCREEN, EUROBIOIMAGING, EVA-G, INFRAFRONTIER, INFRAVEC, INSTRUCT, MIRRI, SONAR GLOBAL, TRANSVAC, VETBIONET and ERINHA.
Contact: contact@isidore-project.eu
Diana Stepanyan, Head of External Affairs
Dylan Bonfils, Communication Officer

Download the press release